Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Brodalumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Valeant's Biologic Siliq (brodalumab) Receives Approval in the U.S.
    Valeant's Biologic Siliq (brodalumab) Receives Approval in the U.S.

    19 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032

    FDA
    19 Jul 2023
    Share Share
    Ortho Dermatologics to Present Data at 2022 Innovations Dermatology Conference
    Ortho Dermatologics to Present Data at 2022 Innovations Dermatology Conference

    01 Nov 2022

    // ACCESSWIRE

    https://www.accesswire.com/723138/Ortho-Dermatologics-to-Present-New-Data-at-the-2022-Innovations-in-Dermatology-Conference

    ACCESSWIRE
    01 Nov 2022
    Share Share
    Valeant Luxembourg 's Siliq (brodalumab) Receives Approval in the U.S.
    Valeant Luxembourg 's Siliq (brodalumab) Receives Approval in the U.S.

    15 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761032

    FDA
    15 Jun 2022
    Share Share
    Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology
    Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology

    19 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/ortho-dermatologics-to-present-new-data-at-the-2021-fall-clinical-dermatology-conference-301402874.html

    PRNEWSWIRE
    19 Oct 2021
    Share Share
    LEO Pharma initiates head-to-head study to evaluate brodalumab vs. guselkumab
    LEO Pharma initiates head-to-head study to evaluate brodalumab vs. guselkumab

    13 Jan 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210112006175/en

    BUSINESSWIRE
    13 Jan 2021
    Share Share
    LEO Pharma initiates head-to-head study to evaluate brodalumab
    LEO Pharma initiates head-to-head study to evaluate brodalumab

    13 Jan 2021

    // PRESS RELEASE

    https://leo-pharma.com/media-center/news/leo-pharma-initiates-head-to-head-study-to-evaluate-brodalumab-versus-guselkumab

    PRESS RELEASE
    13 Jan 2021
    Share Share